
Dry Eye Syndrome Treatment Market Size, Share & Trends Analysis Report By Type, By Drug, By Product, By Dosage Form, By Sales Channel, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
Description
Dry Eye Syndrome Treatment Market Size, Share & Trends Analysis Report By Type, By Drug, By Product, By Dosage Form, By Sales Channel, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
Pet Monitoring Camera Market Growth & Trends
The global pet monitoring camera market size is estimated to reach USD 453.6 million by 2030, registering to grow at a CAGR of 12.6% from 2025 to 2030 according to a new report by Grand View Research, Inc. Continuous surge in pet ownership among millennial population has been driving the growth. Furthermore, the rapid adoption of the latest technology among consumers is expected to increasing spending on advanced monitoring products for pets.
The one-way video functionality accounted for more than 85% of the market share in terms of revenue. Over the past few years, the consumers have been attracted to the innovative features of these products. Manufacturers have added features, including laser dot chase game, automatic treat dispenser, motion and sound detection, and built-in ringtone, to their monitoring devices. Furthermore, two-way voice communication has made these devices more interactive.
The rising popularity of e-commerce among consumers due to the convenience of shopping is expected to boost the segment in near future. Major online retailers include Amazon; PetSmart Inc.; Walmart; Target Brands, Inc.; eBay Inc.; and Petco Animal Supplies, Inc. The Asia Pacific pet monitoring camera market is expected to grow at the highest CAGR over the forecast period. Prominent markets of this region include China, Japan, Australia, and India. Over the past few years, increased number of pets in the aforementioned countries has been witnessed. For instance, According to the Japan Pet Food Association, the number of domestic cats has increased by 123,000 to more than 9 million from 2017 to 2018. Additionally, high number of millennial population in developing economies including China and India is expected to open new avenues over the next few years.
Key competitors in the pet monitoring camera market include Furbo Dog Camera (Tomofun LLC); Motorola Mobility LLC; Petcube; Inc; Zmodo; Acer Inc. (Pawbo Inc.); SpotCam Co., Ltd.; Hangzhou Hikvision Digital Technology Co., Ltd. (Ezviz Inc.); Vimtag Technology Co., Ltd; The Clever Dog Company; PetChatz LLC.
Pet Monitoring Camera Market Report Highlights
- The one-way video functionality segment accounted for the largest revenue share of 87.5% in 2024 due to the simplicity and effectiveness of these devices, allowing pet owners to monitor their pets remotely through live video feeds.
- The offline segment dominated the market with the largest revenue share in 2024 due to the established presence of retail stores and the preference of many consumers to purchase products in person.
- The North America pet monitoring camera market dominated with the largest revenue share of 51.8% in 2024.
Table of Contents
120 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Drugs
- 1.2.3. Product
- 1.2.4. Dosage Form
- 1.2.5. Sales Channel
- 1.2.6. Distribution Channel
- 1.2.7. Regional Scope
- 1.2.8. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR’s internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Type outlook
- 2.2.2. Drugs outlook
- 2.2.3. Product outlook
- 2.2.4. Dosage form outlook
- 2.2.5. Sales channel outlook
- 2.2.6. Distribution channel outlook
- 2.3. Regional outlook
- 2.4. Competitive Insights
- Chapter 3. Dry Eye Syndrome Treatment Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing geriatric population
- 3.2.1.2. Increasing prevalence of dry eye syndrome
- 3.2.1.3. Robust product pipeline
- 3.2.1.4. Growing disease awareness and increasing use of contact lenses
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Competition from generic products
- 3.2.2.2. High cost of treatments and lack of awareness among the general population in low- and middle-income countries
- 3.3. Dry Eye Syndrome Treatment Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitutes
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Technological landscape
- 3.3.2.5. Environmental landscape
- 3.3.2.6. Legal landscape
- Chapter 4. Dry Eye Syndrome Treatment Market: Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Dry Eye Syndrome Treatment Market: Type Movement Analysis
- 4.3. Dry Eye Syndrome Treatment Market by Type Outlook (USD Million)
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5. Evaporative Dry Eye Syndrome
- 4.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 4.6. Aqueous Deficient Dry Eye Syndrome
- 4.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- Chapter 5. Dry Eye Syndrome Treatment Market: Drugs Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Dry Eye Syndrome Treatment Market: Drugs Movement Analysis
- 5.3. Dry Eye Syndrome Treatment Market by Drugs Outlook (USD Million)
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5. Xiidra
- 5.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.6. Restasis
- 5.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.7. Cequa
- 5.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.8. Tyrvaya
- 5.8.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.9. Eysuvis
- 5.9.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 5.10. Others
- 5.10.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- Chapter 6. Dry Eye Syndrome Treatment Market: Product Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Dry Eye Syndrome Treatment Market: Product Movement Analysis
- 6.3. Dry Eye Syndrome Treatment Market by Product Outlook (USD Million)
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5. Artificial Tears
- 6.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.6. Cyclosporine
- 6.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.7. Topical Corticosteroids
- 6.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.8. Punctal Plugs
- 6.8.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.9. Oral Omega Supplements
- 6.9.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 6.10. Others
- 6.10.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- Chapter 7. Dry Eye Syndrome Treatment Market: Dosage Form Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Dry Eye Syndrome Treatment Market: Dosage Form Movement Analysis
- 7.3. Dry Eye Syndrome Treatment Market by Dosage Form Outlook (USD Million)
- 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5. Eye Drops/ Solutions
- 7.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.6. Ointments and Gels
- 7.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.7. Capsules & Tablets (For Supplements)
- 7.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 7.8. Other Dosage Forms
- 7.8.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- Chapter 8. Dry Eye Syndrome Treatment Market: Sales Channel Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Dry Eye Syndrome Treatment Market: Sales Channel Movement Analysis
- 8.3. Dry Eye Syndrome Treatment Market by Sales Channel Outlook (USD Million)
- 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 8.5. Prescription
- 8.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.6. OTC
- 8.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 8.7. Others
- 8.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- Chapter 9. Dry Eye Syndrome Treatment Market: Distribution Channel Estimates & Trend Analysis
- 9.1. Segment Dashboard
- 9.2. Dry Eye Syndrome Treatment Market: Distribution Channel Movement Analysis
- 9.3. Dry Eye Syndrome Treatment Market by Distribution Channel Outlook (USD Million)
- 9.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 9.5. Retail Pharmacies
- 9.5.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.6. Hospital Pharmacies
- 9.6.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- 9.7. Online Pharmacies
- 9.7.1. Market Estimates And Forecast, 2018 - 2030 (USD Million)
- Chapter 10. Dry Eye Syndrome Treatment Market: Regional Estimates & Trend Analysis
- 10.1. Regional Dashboard
- 10.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 10.3. North America
- 10.3.1. U.S.
- 10.3.1.1. Key country dynamics
- 10.3.1.2. Regulatory framework/ reimbursement structure
- 10.3.1.3. Competitive scenario
- 10.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 10.3.2. Canada
- 10.3.2.1. Key country dynamics
- 10.3.2.2. Regulatory framework/ reimbursement structure
- 10.3.2.3. Competitive scenario
- 10.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 10.3.3. Mexico
- 10.3.3.1. Key country dynamics
- 10.3.3.2. Regulatory framework/ reimbursement structure
- 10.3.3.3. Competitive scenario
- 10.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 10.4. Europe
- 10.4.1. UK
- 10.4.1.1. Key country dynamics
- 10.4.1.2. Regulatory framework/ reimbursement structure
- 10.4.1.3. Competitive scenario
- 10.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 10.4.2. Germany
- 10.4.2.1. Key country dynamics
- 10.4.2.2. Regulatory framework/ reimbursement structure
- 10.4.2.3. Competitive scenario
- 10.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 10.4.3. France
- 10.4.3.1. Key country dynamics
- 10.4.3.2. Regulatory framework/ reimbursement structure
- 10.4.3.3. Competitive scenario
- 10.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 10.4.4. Italy
- 10.4.4.1. Key country dynamics
- 10.4.4.2. Regulatory framework/ reimbursement structure
- 10.4.4.3. Competitive scenario
- 10.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 10.4.5. Spain
- 10.4.5.1. Key country dynamics
- 10.4.5.2. Regulatory framework/ reimbursement structure
- 10.4.5.3. Competitive scenario
- 10.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 10.4.6. Norway
- 10.4.6.1. Key country dynamics
- 10.4.6.2. Regulatory framework/ reimbursement structure
- 10.4.6.3. Competitive scenario
- 10.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 10.4.7. Sweden
- 10.4.7.1. Key country dynamics
- 10.4.7.2. Regulatory framework/ reimbursement structure
- 10.4.7.3. Competitive scenario
- 10.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 10.4.8. Denmark
- 10.4.8.1. Key country dynamics
- 10.4.8.2. Regulatory framework/ reimbursement structure
- 10.4.8.3. Competitive scenario
- 10.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 10.5. Asia Pacific
- 10.5.1. Japan
- 10.5.1.1. Key country dynamics
- 10.5.1.2. Regulatory framework/ reimbursement structure
- 10.5.1.3. Competitive scenario
- 10.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 10.5.2. China
- 10.5.2.1. Key country dynamics
- 10.5.2.2. Regulatory framework/ reimbursement structure
- 10.5.2.3. Competitive scenario
- 10.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 10.5.3. India
- 10.5.3.1. Key country dynamics
- 10.5.3.2. Regulatory framework/ reimbursement structure
- 10.5.3.3. Competitive scenario
- 10.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 10.5.4. Australia
- 10.5.4.1. Key country dynamics
- 10.5.4.2. Regulatory framework/ reimbursement structure
- 10.5.4.3. Competitive scenario
- 10.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 10.5.5. South Korea
- 10.5.5.1. Key country dynamics
- 10.5.5.2. Regulatory framework/ reimbursement structure
- 10.5.5.3. Competitive scenario
- 10.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 10.5.6. Thailand
- 10.5.6.1. Key country dynamics
- 10.5.6.2. Regulatory framework/ reimbursement structure
- 10.5.6.3. Competitive scenario
- 10.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 10.6. Latin America
- 10.6.1. Brazil
- 10.6.1.1. Key country dynamics
- 10.6.1.2. Regulatory framework/ reimbursement structure
- 10.6.1.3. Competitive scenario
- 10.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 10.6.2. Argentina
- 10.6.2.1. Key country dynamics
- 10.6.2.2. Regulatory framework/ reimbursement structure
- 10.6.2.3. Competitive scenario
- 10.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 10.7. MEA
- 10.7.1. South Africa
- 10.7.1.1. Key country dynamics
- 10.7.1.2. Regulatory framework/ reimbursement structure
- 10.7.1.3. Competitive scenario
- 10.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 10.7.2. Saudi Arabia
- 10.7.2.1. Key country dynamics
- 10.7.2.2. Regulatory framework/ reimbursement structure
- 10.7.2.3. Competitive scenario
- 10.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 10.7.3. UAE
- 10.7.3.1. Key country dynamics
- 10.7.3.2. Regulatory framework/ reimbursement structure
- 10.7.3.3. Competitive scenario
- 10.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 10.7.4. Kuwait
- 10.7.4.1. Key country dynamics
- 10.7.4.2. Regulatory framework/ reimbursement structure
- 10.7.4.3. Competitive scenario
- 10.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- Chapter 11. Competitive Landscape
- 11.1. Company Categorization
- 11.2. Recent Developments & Impact Analysis by Key Market Participants
- 11.3. Company Market Share Analysis, 2024
- 11.4. Company overview
- 11.4.1. Novartis AG
- 11.4.1.1. Company Overview
- 11.4.1.2. Financial performance
- 11.4.1.3. Product benchmarking
- 11.4.1.4. Strategic initiatives
- 11.4.2. AbbVie, Inc.
- 11.4.2.1. Company Overview
- 11.4.2.2. Financial performance
- 11.4.2.3. Product benchmarking
- 11.4.2.4. Strategic initiatives
- 11.4.3. Sun Pharmaceutical Industries Ltd.
- 11.4.3.1. Company Overview
- 11.4.3.2. Financial performance
- 11.4.3.3. Product benchmarking
- 11.4.3.4. Strategic initiatives
- 11.4.4. Santen Pharmaceutical Co Ltd.
- 11.4.4.1. Company Overview
- 11.4.4.2. Financial performance
- 11.4.4.3. Product benchmarking
- 11.4.4.4. Strategic initiatives
- 11.4.5. AFT Pharmaceuticals
- 11.4.5.1. Company Overview
- 11.4.5.2. Financial performance
- 11.4.5.3. Product benchmarking
- 11.4.5.4. Strategic initiatives
- 11.4.6. Johnson & Johnson Services, Inc.
- 11.4.6.1. Company Overview
- 11.4.6.2. Financial performance
- 11.4.6.3. Product benchmarking
- 11.4.6.4. Strategic initiatives
- 11.4.7. Otsuka Pharmaceutical Co., Ltd. (subsidiary of Otsuka Holdings Co., Ltd.)
- 11.4.7.1. Company Overview
- 11.4.7.2. Financial performance
- 11.4.7.3. Product benchmarking
- 11.4.7.4. Strategic initiatives
- 11.4.8. OASIS Medical
- 11.4.8.1. Company Overview
- 11.4.8.2. Financial performance
- 11.4.8.3. Product benchmarking
- 11.4.8.4. Strategic initiatives
- 11.4.9. Oyster Point Pharma, Inc. (acquired by Viatris Inc. in January 2023)
- 11.4.9.1. Company Overview
- 11.4.9.2. Financial performance
- 11.4.9.3. Product benchmarking
- 11.4.9.4. Strategic initiatives
- 11.4.10. Bausch Health Companies, Inc.
- 11.4.10.1. Company Overview
- 11.4.10.2. Financial performance
- 11.4.10.3. Product benchmarking
- 11.4.10.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.